A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
CA 2398445 C · Owner: Stevia Aps · Inventors: Hermansen, Kjeld; Gregersen, Soren; Jeppesen, Per Bendix
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A substance including the chemical structures of bicyclo3.2.1octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The unique chemical structures of bicyclo3.2.1octan alone or in a kaurene structure provides the substances, such as e.g. steviol isosteviol and stevioside with , the capability of enhancing or potentiating the secretion of insulin in a plasma glucose dependent manner. The substances including these unique chemical structures also have the capability of reducing the glucagon concentration in the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 1, 2001 and granted April 3, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 1, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 1, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.